Improved oral anticancer medication (OAM) adherence/toxicity assessment documentation: A quality improvement initiative
Journal of Oncology Pharmacy Practice
Published online on May 13, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
IntroductionAdherence and toxicity symptoms ideally are monitored within 7–14 days after initiating oral anticancer medication (OAM). After implementing a formal OAM program at our institution, we found our adherence and toxicity monitoring was suboptimal ...
IntroductionAdherence and toxicity symptoms ideally are monitored within 7–14 days after initiating oral anticancer medication (OAM). After implementing a formal OAM program at our institution, we found our adherence and toxicity monitoring was suboptimal ...